Demand for Covid Products to Remain High: Merck KGaA CEO

Mar.04 — Merck KGaA Chief Executive Officer Stephan Oschmann says that while the Covid-19 vaccine rollout is “encouraging,” he expects the virus “will be endemic in future.” Oschmann spoke on Bloomberg Television after the company predicted record earnings in 2021 amid high demand for pandemic-related products including components used in lab testing and vaccine development. (Corrects company name in headline and description.)

Articles You May Like

Introducing StockTracker Master Class Volume 1